Picture of Permian Basin Royalty Trust logo

PBT — Permian Basin Royalty Trust News Story

0.000.00%
us flag iconLast trade - 00:00
EnergyBalancedMid CapHigh Flyer

U.S. STOCKS ON THE MOVE-Spring Bank Pharmaceuticals, Microbot Medical, Qiagen, Hexo Corp

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh


    U.S. stock index futures were near record highs on Thursday on optimism that
an initial U.S.-China trade deal would be signed soon, easing a dispute that has
rattled global markets for the past 17 months.  .N 
    At 7:46 ET, Dow e-minis  1YMc1  were up 0.11% at 28,538. S&P 500 e-minis
 ESc1  were up 0.14% at 3,230.25, while Nasdaq 100 e-minis  NQc1  were up 0.11%
at 8,738.75.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Overseas Shipholding Group Inc  OSG , up 15.6%
 ** Pacific Coast Oil Trust  ROYT.N , up 13.5%
 ** Permian Basin Royalty Trust  PBT , up 5.4%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Qiagen N V  QGEN.N , down 27.9%
 ** Hexo Corp  HEXO.K , down 14.3%
 ** Lg Display Co  LPL.N , down 4.2%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Inpixon  INPX.O , up 27.3%
 ** Helius Medical Technologies Inc  HSDT.O , up 25.5%
 ** Newlink Genetics Corp  NLNK.O , up 21.5%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Spectrum Pharmaceuticals Inc  SPPI.O , down 33.1%
 ** Spring Bank Pharmaceuticals Inc  SBPH.O , down 30.7%
 ** Microbot Medical Inc  MBOT.O , down 23.2%
 
 
 ** Spring Bank Pharmaceuticals Inc  SBPH.O : down 30.7% premarket
 BUZZ-Spring Bank Pharma: Down after co stops trial of drug for hepatitis B
virus  urn:newsml:reuters.com:*:nL4N2901E3
 
 ** Microbot Medical  MBOT.O : down 23.2% premarket
 BUZZ-Microbot Medical: Plunges on discounted stock offer to raise funds for
robot development  urn:newsml:reuters.com:*:nL4N2901F1
 
 ** Spectrum Pharmaceuticals Inc  SPPI.O : down 33.1% premarket
 BUZZ-Spectrum Pharma plunges after cancer drug fails mid-stage trial
 urn:newsml:reuters.com:*:nL4N2901H9

 (Compiled by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91
80 6749 7786;))

Recent news on Permian Basin Royalty Trust

See all news